KDM6A and hepatocellular carcinoma: In conclusion, our findings demonstrate that KDM6A overexpression modulates malignant phenotypes in HCC cells by inhibiting proliferation, disrupting EMT, and promoting hepatic differentiation through the regulation/modulation of key genes including c-MYC, CCNB1, HNF4α, and downstream targets.